Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2023 Feb 16;20(4):3476.
doi: 10.3390/ijerph20043476.

Beyond Sentinel Lymph Node: Outcomes of Indocyanine Green-Guided Pelvic Lymphadenectomy in Endometrial and Cervical Cancer

Benito Chiofalo  1 , Antonio Simone Laganà  2 , Fabio Ghezzi  3 , Camilla Certelli  1 , Jvan Casarin  3 , Valentina Bruno  1 , Isabella Sperduti  4 , Vito Chiantera  2 , Panagiotis Peitsidis  5 , Enrico Vizza  1
Affiliations
Multicenter Study

Beyond Sentinel Lymph Node: Outcomes of Indocyanine Green-Guided Pelvic Lymphadenectomy in Endometrial and Cervical Cancer

Benito Chiofalo et al. Int J Environ Res Public Health. .

Abstract

Background: The aim of our study was to compare the number of lymph nodes removed during indocyanine green (ICG)-guided laparoscopic/robotic pelvic lymphadenectomy with standard systematic lymphadenectomy in endometrial cancer (EC) and cervical cancer (CC).

Methods: This is a multicenter retrospective comparative study (Clinical Trial ID: NCT04246580; updated on 31 January 2023). Women affected by EC and CC who underwent laparoscopic/robotic systematic pelvic lymphadenectomy, with (cases) or without (controls) the use of ICG tracer injection within the uterine cervix, were included in the study.

Results: The two groups were homogeneous for age (p = 0.08), Body Mass Index, International Federation of Gynaecology and Obstetrics (FIGO) stages (p = 0.41 for EC; p = 0.17 for CC), median estimated blood loss (p = 0.76), median operative time (p = 0.59), and perioperative complications (p = 0.66). Nevertheless, the number of lymph nodes retrieved during surgery was significantly higher (p = 0.005) in the ICG group (n = 18) compared with controls (n = 16).

Conclusions: The accurate and precise dissection achieved with the use of the ICG-guided procedure was associated with a higher number of lymph nodes removed in the case of systematic pelvic lymphadenectomy for EC and CC.

Keywords: cervical cancer; endometrial cancer; gynecologic oncology; indocyanine green; laparoscopy; minimally invasive surgery; pelvic lymphadenectomy; robotic surgery.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Median number of harvest lymph nodes in patients who underwent either ICG guided systematic pelvic lymphadenectomy (ICG-LND) or standard systematic pelvic lymphadenectomy without ICG (Conventional-LND): (a) overall (endometrial and cervical cancer); (b) endometrial cancer; (c) cervical cancer.
See this image and copyright information in PMC

References

    1. Yang W., Qiang J.W., Tian H.P., Chen B., Wang A.J., Zhao J.G. Multi-Parametric MRI in Cervical Cancer: Early Prediction of Response to Concurrent Chemoradiotherapy in Combination with Clinical Prognostic Factors. Eur. Radiol. 2018;28:437–445. doi: 10.1007/s00330-017-4989-3. - DOI - PubMed
    1. Cignini P., Vitale S.G., Laganà A.S., Biondi A., La Rosa V.L., Cutillo G. Preoperative Work-up for Definition of Lymph Node Risk Involvement in Early Stage Endometrial Cancer: 5-Year Follow-Up. Updates Surg. 2017;69:75–82. doi: 10.1007/s13304-017-0418-z. - DOI - PubMed
    1. Takekuma M., Kasamatsu Y., Kado N., Kuji S., Tanaka A., Takahashi N., Abe M., Hirashima Y. The Issues Regarding Postoperative Adjuvant Therapy and Prognostic Risk Factors for Patients with Stage I-II Cervical Cancer: A Review. J. Obstet. Gynaecol. Res. 2017;43:617–626. doi: 10.1111/jog.13282. - DOI - PubMed
    1. Cowan M., Strauss J.B., Barber E.L., Matei D. Updates on Adjuvant Chemotherapy and Radiation Therapy for Endometrial Cancer. Curr. Opin. Obstet. Gynecol. 2019;31:31–37. doi: 10.1097/GCO.0000000000000506. - DOI - PubMed
    1. Cibula D., Pötter R., Planchamp F., Avall-Lundqvist E., Fischerova D., Haie Meder C., Köhler C., Landoni F., Lax S., Lindegaard J.C., et al. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer. Radiother. Oncol. 2018;127:404–416. doi: 10.1016/j.radonc.2018.03.003. - DOI - PubMed

Publication types

Associated data